Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic

Laidlaw, Stephen M., Ulaeto, David, Lonsdale, Steve, Clark, Graeme, Sumner, Rebecca, Edwards, Thomas, Adams, Emily ORCID: https://orcid.org/0000-0002-0816-2835, Logist, Anne-Sophie, Van Holm, Bram, Maluquer de Motes, Carlos, Horby, Peter, Maes, Piet and Carroll, Miles W. (2025) 'Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic'. Microbiology Spectrum. (In Press)

Text laidlaw-et-al-2025-detection-of-mpox-and-other-orthopoxviruses-using-a-lateral-flow-device-as-a-point-of-care-diagnostic.pdf - Published Version Available under License Creative Commons Attribution. Download (3MB)

Abstract

In 2022, the World Health Organization declared the worldwide outbreak of mpox to be a public health emergency of international concern. The causative monkeypox virus (MPXV) belonged to clade IIb and is transmitted through sexual contact with a low case fatality rate (0.1%), which, together with under-detection, all contributed to a rapid global spread particularly within the MSM (men who have sex with men) community. As MPXV clade II remains circulating worldwide, a new outbreak of the more fatal clade I disease has been declared in Central and East Africa, and remains uncontrolled in part due to the lack of point-of-care (POC) diagnostics for rapid decisions on treatment and self-isolation. To address the lack of POC solutions for mpox, we have designed and evaluated an orthopoxvirus-specific lateral flow device (LFD) that could be used for the diagnosis of mpox. Using an LFD comprising four monoclonal antibodies against the A27 protein, we demonstrate sensitivity to 3 × 10 5 pfu/mL. This sensitivity is expected to be sufficient for the detection of MPXV from lesion sites and may also be sufficient for other sample types such as saliva and urine. We found that the presence of guanidinium thiocyanate, a common ingredient in inactivating viral transport media, masked the LFD antigen, resulting in false negatives. POC diagnosis of mpox may be possible using an LFD to reduce delays arising from sample shipment to centralized laboratory testing facilities. In order to achieve this, our work demonstrates that an LFD-optimized buffer is required, as the sample collection buffer may have a detrimental impact on sensitivity for clinical material. IMPORTANCE Mpox cases have dramatically increased both in traditionally monkeypox virus endemic countries and also worldwide. This increase comes at a time when immunity derived from smallpox vaccination is no longer available. Diagnosis of mpox is complicated due to both disease presentation and the availability of local diagnostic laboratories. The availability of a point-of-care diagnostic tool such as an lateral flow device (LFD) would play an important role to both diagnose and prevent onward transmission. This manuscript provides developers and assessors with key data for defining true sensitivity and specificity of a successful LFD in addition to buffer conditions for sample collection.

Item Type:	Article
Subjects:	QY Clinical Pathology > QY 4 General works WC Communicable Diseases > WC 20 Research (General) WC Communicable Diseases > Virus Diseases > Infectious Viral Skin Diseases > WC 570 Infectious viral skin diseases
Faculty: Department:	Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI):	https://doi.org/10.1128/spectrum.02456-24
SWORD Depositor:	JISC Pubrouter
Depositing User:	JISC Pubrouter
Date Deposited:	19 Mar 2025 11:07
Last Modified:	19 Mar 2025 11:07
URI:	https://archive.lstmed.ac.uk/id/eprint/26297

Statistics

View details

Actions (login required)

Edit Item